Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2026-03-08 @ 10:21 AM
Study NCT ID:
NCT02538627
Status:
TERMINATED
Last Update Posted:
2017-09-05
First Post:
2015-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Sponsor:
Merrimack Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2016-10-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-31
First Submit QC Date:
None
Study First Post Date:
2015-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-31
Last Update Post Date:
2017-09-05
Last Update Post Date Type:
ACTUAL